Abstract
This month's Genome Watch highlights how a population study, in conjunction with a reference genome, can identify the evolutionary features that contribute to drug resistance in a protozoan parasite.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Chain, P. S. G. et al. Genome project standards in a new era of sequencing. Science 326, 236–237 (2009).
Zucca, M. & Savoia, D. Current developments in the therapy of protozoan infections. Open Med. Chem. J. 5, 4–10 (2011).
Pérez-Victoria, F. J., Sánchez-Cañete, M. P., Castanys, S. & Gamarro, F. Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites. J. Biol. Chem. 281, 23766–23775 (2006).
Peacock, C. S. et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nature Genet. 39, 839–847 (2007).
Downing, T. et al. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 21, 2143–2156 (2011).
Leprohon, P. et al. Gene expression modulation is associated with gene amplification, supernumerary chromosomes and chromosome loss in antimony-resistant Leishmania infantum. Nucleic Acids Res. 37, 1387–1399 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Sanchez-Flores, A. Sequencing parasite populations. Nat Rev Microbiol 10, 85 (2012). https://doi.org/10.1038/nrmicro2738
Published:
Issue date:
DOI: https://doi.org/10.1038/nrmicro2738
